| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/06/2006 | US20060073151 Inhibitors of extracellular Hsp90 |
| 04/06/2006 | US20060073150 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 04/06/2006 | US20060073149 Rapid improvement of cognition in condition related to abeta |
| 04/06/2006 | US20060073148 IL-13 binding agents |
| 04/06/2006 | US20060073147 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 04/06/2006 | US20060073146 Uses of agonists and antagonists to modulate activity of TNF-related molecules |
| 04/06/2006 | US20060073145 Methods and compositions for inhibiting CD14 mediated cell activation |
| 04/06/2006 | US20060073144 Individualized anti-cancer antibodies |
| 04/06/2006 | US20060073143 Treatment with anti-ErbB2 antibodies and anti-hormonal compounds |
| 04/06/2006 | US20060073142 Anti-Fc-gamma RIIB receptor antibody and uses therefor |
| 04/06/2006 | US20060073141 Compositions and methods for treating inflammatory disorders |
| 04/06/2006 | US20060073140 Dual-specificity antibody having specificity for both an activated erbB2 receptor and erbB1 dimers, without significant affinity for monomeric EGFr that is not activate; specificity of the antibodies is due to their recognition and binding of activation epitopes; diagnosis, imaging and for treating tumor |
| 04/06/2006 | US20060073139 Vaccine composition for preventing meningococcal disease |
| 04/06/2006 | US20060073138 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 04/06/2006 | US20060073137 Humanised antibodies |
| 04/06/2006 | US20060073136 Humanised antibodies |
| 04/06/2006 | US20060073135 Methods and compositions for modulating and detecting wisp activity |
| 04/06/2006 | US20060073134 Determining in a pancreas sample the level of expression of a marker protein; islet cell regeneration factor; lithostathine 1 alpha, leukocyte elastase inhibitor, lipocalin-2; indicates diabetes |
| 04/06/2006 | US20060073133 Sialoadhesin factor-3 antibodies |
| 04/06/2006 | US20060073126 Cytotoxic T lymphocyte |
| 04/06/2006 | US20060073125 Isolation and use of solid tumor stem cells |
| 04/06/2006 | US20060073123 Adenovirus vectors for immunotherapy |
| 04/06/2006 | US20060073118 Methods of activating NKT cells |
| 04/06/2006 | US20060073117 Methods and compositions for controlling hair follicle stem cell fate |
| 04/06/2006 | US20060073100 Detection and therapy of vulnerable plaque with fluorescent and/or radiolabeled compositions |
| 04/06/2006 | DE102004054545A1 Änderung des Beladungszustandes von MHC-Molekülen Changing the load state of MHC molecules |
| 04/06/2006 | DE102004046391A1 Neuer Impfstoff für veterinäre und humanmedizinische Prophylaxe und Therapie New vaccine for veterinary and human medical prophylaxis and therapy |
| 04/06/2006 | CA2581980A1 Methods for treating conditions associated with the accumulation of excess extracellular matrix |
| 04/06/2006 | CA2581966A1 Group a streptococcus crge protein |
| 04/06/2006 | CA2581840A1 Optimized vaccines to provide protection against ebola and other viruses |
| 04/06/2006 | CA2581815A1 Liquid allergy vaccine formulation for oromucosal administration |
| 04/06/2006 | CA2581331A1 Listeria-based and llo-based vaccines |
| 04/06/2006 | CA2580122A1 Clostridial neurotoxins for use in tissue healing |
| 04/06/2006 | CA2579471A1 Stabilization of alum-adjuvanted immunologically active agents |
| 04/06/2006 | CA2563399A1 Stabilized biodegradable neurotoxin implants |
| 04/05/2006 | EP1642987A2 Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of these viral genomes and to the in vitro diagnosis of infections resulting from these viruses |
| 04/05/2006 | EP1642975A2 Chemokine receptors 88-2B (CKR-3) and their antibodies |
| 04/05/2006 | EP1642973A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642972A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642968A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642967A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642910A1 Rationally designed antibodies |
| 04/05/2006 | EP1642909A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 04/05/2006 | EP1642907A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642906A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642905A1 Immunogenic T-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
| 04/05/2006 | EP1642596A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/05/2006 | EP1642132A2 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 04/05/2006 | EP1641927A2 Induced activation in dendritic cells |
| 04/05/2006 | EP1641926A2 Therapeutic use of lpi, a staphylococcal lectin pathway inhibitor in inflammatory diseases |
| 04/05/2006 | EP1641827A2 Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions |
| 04/05/2006 | EP1641826A2 Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions |
| 04/05/2006 | EP1641822A2 Il-17 a/f heterologous polypeptides and therapeutic uses thereof |
| 04/05/2006 | EP1641819A1 Purification of her-2 variants |
| 04/05/2006 | EP1641492A2 Controlled platelet activation to monitor therapy of adp antagonists |
| 04/05/2006 | EP1641488A1 Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin |
| 04/05/2006 | EP1641479A2 Inhibition of stress-induced ligand-dependent egfr activation |
| 04/05/2006 | EP1641474A1 Therapeutical composition containing dentritic cells and use thereof |
| 04/05/2006 | EP1641424A2 Programmed immune responses using a vaccination node |
| 04/05/2006 | EP1401489B1 Capsular polysaccharide solubilisation |
| 04/05/2006 | EP1353689B1 Immunizing compositions and methods of use |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | EP1107783B1 Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor |
| 04/05/2006 | EP1049718B1 Use of the antibody 271.14d9.f8 (dsm acc2331) to inhibit in vitro alphavbeta6-integrin attachment to fibronectin |
| 04/05/2006 | EP1017840B1 NOVEL $i(SERRATIA MARCESCENS) STRAIN, PRODIGIOSIN AND THE USE OF THE SAME AS AN IMMUNOSUPPRESSIVE |
| 04/05/2006 | EP0946188B1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 04/05/2006 | EP0871673B1 Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety |
| 04/05/2006 | EP0784486B1 Interleukin-12 as an adjuvant for paramyxoviridae vaccines |
| 04/05/2006 | EP0741792B1 Herpesvirus pre-(viral dna replication) enveloped particles |
| 04/05/2006 | EP0729507B1 Composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor |
| 04/05/2006 | EP0649435B1 Membrane-associated immunogens of mycobacteria |
| 04/05/2006 | EP0618965B1 Method for generating structural and functional diversity in a peptide sequence |
| 04/05/2006 | CN1756843A Streptococcus pyogenes antigens |
| 04/05/2006 | CN1756842A Branched neutral amino acid transporters acting as single molecule |
| 04/05/2006 | CN1756768A Trimeric polypeptide construct to induce an enduring t cell response |
| 04/05/2006 | CN1756763A Dimerized peptide |
| 04/05/2006 | CN1756568A Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| 04/05/2006 | CN1756565A Compositions for the treatment of mycobacterial infections |
| 04/05/2006 | CN1756564A Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells |
| 04/05/2006 | CN1756563A Use of myxoma virus for therapeutic treatment of cancer and chronic viral infection |
| 04/05/2006 | CN1756562A Influenza virus vaccine |
| 04/05/2006 | CN1756561A Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins |
| 04/05/2006 | CN1756560A Complement receptor 2 targeted complement modulators |
| 04/05/2006 | CN1754959A Preparation process and application of genetic engineering subunit vaccine of infectious bursal disease |
| 04/05/2006 | CN1754573A Use of immunoglobulin and cell growth factor in preparing medicine for asthma |
| 04/05/2006 | CN1249242C non-resistance choosing for DNA vaccine carrier and its construction method |
| 04/05/2006 | CN1249241C HIV-like particles and use thereof |
| 04/05/2006 | CN1249240C Expression vector pBVTB, its construction method and use in HCV vaccin research |
| 04/05/2006 | CN1249233C Surface proteins of chlamydia pneumoniae |
| 04/05/2006 | CN1249232C Schistosomiasis japonica (Chinese Continental strain) MFS4 gene clone, expression amd DNA vacine |
| 04/05/2006 | CN1249228C Nucleotide specific to bacillus coli O125 type O-antigen |
| 04/05/2006 | CN1249227C 真菌细胞壁合成基因 Fungal cell wall synthesis genes |
| 04/05/2006 | CN1249087C Novel human G-Protein coupled receptor |
| 04/05/2006 | CN1249085C Immunogenic but non-amyloidogenic synthetic peptides homologous to beta amyloid for induction of immune response to beta amyloid and amyloid deposits |
| 04/05/2006 | CN1249084C Human SARS virus surface membrane protein antigen determinant polypeptide, polynucleotide sequence and its use |
| 04/05/2006 | CN1248740C AIDS virus vaccine with use of sendai virus vector |
| 04/05/2006 | CN1248737C Vaccine containing saponin and sterol |
| 04/05/2006 | CN1248736C 疫苗组合物 Vaccine compositions |
| 04/05/2006 | CA2479539A1 Recombinant adenylate cyclase / hiv-tat protein and therapeutic and diagnostic uses thereof |
| 04/04/2006 | US7022830 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |